The effect of minimal inflammation on patients with maintenance hemodialysis and the intervention effect of fluvastatin
10.3760/cma.j.issn.1008-6315.2009.08.013
- VernacularTitle:微炎症状态对维持性血液透析患者的影响及氟伐他汀的干预作用
- Author:
Huanrong YANG
;
Shufang CAI
;
Bingxia XU
;
Lingling CHANG
;
Xiaosu ZHANG
;
Wenbin WU
- Publication Type:Journal Article
- Keywords:
Hemodialysis;
Fluvastatin;
Inflammation;
Malnutrition
- From:Clinical Medicine of China
2009;25(8):820-823
- CountryChina
- Language:Chinese
-
Abstract:
Objective To invest the effect of minimal inflammation on patients with maintenance hemodialysis(MHD) and the intervention effect of ftuvastatin.Methods Blood indicators such as PA,ALB and BUN,Cr,TC,TG,HDL-C,LDL-C,Lp(a),SF,hs-CRP,IL-6 and TNF-α were detected at the first day of the study and six months later in all patients.Patients were divided into inflammation group(CRP≥8 mg/L) and non-inflammation group(CRP<8 mg/L) according to CRP levels.Only inflammation group used fluvastatin.Two groups were observed for six months.Results The level of hs-CRP,IL-6,TNF-α,TG,Lp(a),SF in MHD patients was obviously higher than the normal control group.The level of ALB was obviously lower than the normal control group.The angiocardiopathy incidence of inflammation group was obviously higher than that of the non-inflammation.The more obvious of minimal inflammation,the more significant of lipid metabolism disturbance and malnutrition.Hs-CRP,IL-6,TG,TC,LDL-C and Lp(a) of inflammation group decreased obviously(P<0.01 or P<0.05).ALB、HDL-C increased obviously(P<0.05).Indicators of the non-inflammation had no statistical difference after therapy.Conclusions Patients with MHD generally have minimal inflammation and malnutrition.Minimal inflammation has important effect on the angiocardiopathyincidence,lipid metabolism disturbance and malnutrition.Fluvastatin not only could regulate lipid metabolism but also improve the minimal inflammation of patients with MHD.Early detection and therapy of minimal inflammation has important significance on improving prognosis of patients with MHD.
